IL164796A0 - Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use - Google Patents

Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use

Info

Publication number
IL164796A0
IL164796A0 IL16479603A IL16479603A IL164796A0 IL 164796 A0 IL164796 A0 IL 164796A0 IL 16479603 A IL16479603 A IL 16479603A IL 16479603 A IL16479603 A IL 16479603A IL 164796 A0 IL164796 A0 IL 164796A0
Authority
IL
Israel
Prior art keywords
preparation
themand
pharmaceutical compositions
compositions containing
benzothiazole derivatives
Prior art date
Application number
IL16479603A
Other languages
English (en)
Original Assignee
Applied Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Res filed Critical Applied Res
Publication of IL164796A0 publication Critical patent/IL164796A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16479603A 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use IL164796A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02100417 2002-04-25
PCT/EP2003/004323 WO2003091249A1 (en) 2002-04-25 2003-04-25 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders

Publications (1)

Publication Number Publication Date
IL164796A0 true IL164796A0 (en) 2005-12-18

Family

ID=29265991

Family Applications (2)

Application Number Title Priority Date Filing Date
IL164796A IL164796A (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing them and their use
IL16479603A IL164796A0 (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL164796A IL164796A (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing them and their use

Country Status (23)

Country Link
US (1) US7314878B2 (zh)
EP (1) EP1501828B1 (zh)
JP (1) JP4523289B2 (zh)
KR (1) KR100948469B1 (zh)
CN (1) CN1310911C (zh)
AT (1) ATE383356T1 (zh)
AU (1) AU2003233067B2 (zh)
BR (1) BRPI0309594A8 (zh)
CA (1) CA2481763C (zh)
CY (1) CY1107204T1 (zh)
DE (1) DE60318567T2 (zh)
DK (1) DK1501828T3 (zh)
EA (1) EA009682B1 (zh)
ES (1) ES2297165T3 (zh)
HK (1) HK1075664A1 (zh)
IL (2) IL164796A (zh)
MX (1) MXPA04010474A (zh)
PT (1) PT1501828E (zh)
RS (1) RS51407B (zh)
SI (1) SI1501828T1 (zh)
UA (1) UA78035C2 (zh)
WO (1) WO2003091249A1 (zh)
ZA (1) ZA200408023B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2297165T3 (es) 2002-04-25 2008-05-01 Laboratoires Serono Sa Piperazina-benzotiazoles en calidad de agentes para el tratamiento de trastornos isquemicos cerebrales o trastornos del snc.
PL1696909T3 (pl) * 2003-09-12 2008-04-30 Merck Serono Sa Pochodne benzotiazolu do leczenia cukrzycy
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
EA011614B1 (ru) * 2004-11-17 2009-04-28 Арес Трейдинг С.А. Препараты бензотиазола и их применение
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
EP2137173A2 (en) * 2007-04-17 2009-12-30 Laboratoires Serono SA Process for the preparation of piperazine benzothiazoles
RU2504545C2 (ru) * 2008-05-16 2014-01-20 Ф. Хоффманн-Ля Рош Аг Ингибиторы jnk
RU2572247C2 (ru) * 2010-06-04 2016-01-10 Ф. Хоффманн-Ля Рош Аг Производные 2-амино-пиримидина в качестве ингибиторов jnk
US8471027B2 (en) * 2011-04-06 2013-06-25 Hoffmann-La Roche Inc. Adamantyl compounds
WO2014114186A1 (zh) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Jnk抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153574B2 (ja) * 1997-09-10 2008-09-24 トーアエイヨー株式会社 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
EP1193256A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
ES2297165T3 (es) 2002-04-25 2008-05-01 Laboratoires Serono Sa Piperazina-benzotiazoles en calidad de agentes para el tratamiento de trastornos isquemicos cerebrales o trastornos del snc.

Also Published As

Publication number Publication date
IL164796A (en) 2013-02-28
EP1501828A1 (en) 2005-02-02
ES2297165T3 (es) 2008-05-01
CA2481763C (en) 2011-06-14
ZA200408023B (en) 2005-11-30
BRPI0309594A2 (pt) 2016-11-16
CN1310911C (zh) 2007-04-18
ATE383356T1 (de) 2008-01-15
SI1501828T1 (sl) 2008-04-30
KR20040104572A (ko) 2004-12-10
AU2003233067A1 (en) 2003-11-10
MXPA04010474A (es) 2004-12-13
CA2481763A1 (en) 2003-11-06
JP2006504631A (ja) 2006-02-09
US20050261304A1 (en) 2005-11-24
US7314878B2 (en) 2008-01-01
PT1501828E (pt) 2008-02-11
DE60318567T2 (de) 2009-02-19
RS92804A (en) 2006-12-15
RS51407B (en) 2011-02-28
EP1501828B1 (en) 2008-01-09
HK1075664A1 (en) 2005-12-23
DK1501828T3 (da) 2008-03-10
JP4523289B2 (ja) 2010-08-11
CN1662528A (zh) 2005-08-31
BRPI0309594A8 (pt) 2017-04-11
EA200401423A1 (ru) 2005-04-28
AU2003233067B2 (en) 2009-01-08
WO2003091249A1 (en) 2003-11-06
DE60318567D1 (de) 2008-02-21
KR100948469B1 (ko) 2010-03-17
UA78035C2 (en) 2007-02-15
CY1107204T1 (el) 2012-11-21
EA009682B1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
CY1107204T1 (el) Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
EP1673078A4 (en) BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
BR0317020A (pt) Derivados de hidroxietilamina para o tratamento de doença de alzheimer
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
ATE524169T1 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
SE0403006D0 (sv) New compounds
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
SI1789398T1 (sl) 2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace)
IL164212A0 (en) Thiazolidine carboxamide derivatives, their preparation and pharmaceutical compositions containing them
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
GB0407025D0 (en) Novel compounds
TW200612940A (en) Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament